Bank Hapoalim Named The Banker Magazine’s Bank of the Year in Israel for 2015

December 7, 2015

 

Bank Hapoalim has been chosen as Bank of the Year in Israel for 2015, by the prestigious banking magazine The Banker, a publication of the Financial Times Group.  The award was announced at a ceremony held by The Banker in London.


The Banker’s Bank of the Year award is considered one of the most prestigious awards in the global banking industry. The award is granted based on a combination of data received from banks around the world with analysis by the magazine's experts. In addition to financial performance, other factors taken into account include the bank’s strategy, growth directions, initiatives designed to enhance returns, adoption and implementation of advanced technologies, and more. 

 
In the past year, Bank Hapoalim won similar recognition from the esteemed international magazines "Euromoney" and "Global Finance". In addition, Bank Hapoalim was chosen as the Best Banking Website in Israel and the Leader in Digital Banking in Israel by Global Finance magazine.

 

Zion Kenan, President & CEO of Bank Hapoalim, said: "This is the third time in the past five years that The Banker, a prestigious global magazine, has bestowed the "Best Bank in Israel" award on Bank Hapoalim. Winning this prestigious award, which follows a series of other wins, signifies international recognition of the excellence of the largest and leading bank in Israel, and of our continuous and consistently impressive achievements, based on our cutting edge innovation strategy.  I would like to express my gratitude to our wonderful employees and executives; we were awarded this title thanks to them. We will continue to strive for excellence, improvements to our service and technological infrastructures, and the continued growth and preservation of our leadership position, in line with our strategic plan. "

 

Services and products are subject to local laws and regulations and may not be offered in each jurisdiction. For example, investment services are not being offered in the United States or to US Persons except via our US licensed business (www.hapoalimusa.com) and are being offered only to Canadian customers who qualify as "permitted clients" (as that term is defined under Canadian law).  

WPS1